University of Health Sciences Turkey, İzmir Tepecik Training and Research Hospital, Clinic of Pediatric Infectious Diseases, İzmir, Turkey
İzmir Katip Çelebi University Faculty of Medicine, Department of Pediatric Infectious Diseases, İzmir, Turkey
J Clin Res Pediatr Endocrinol. 2023 May 29;15(2):190-198. doi: 10.4274/jcrpe.galenos.2023.2022-10-1. Epub 2023 Feb 16.
To determine the clinical significance of serum 25-hydroxy (OH) vitamin D levels in pediatric patients with multisystem inflammatory syndrome in children (MIS-C) and compare the vitamin D levels of these patients with those patients with Coronavirus disease-2019 (COVID-19) and healthy controls.
This study was designed for pediatric patients aged 1 month to 18 years and conducted between July 14 and December 25, 2021. Fifty-one patients with MIS-C, 57 who were hospitalized with COVID-19, and 60 controls were enrolled in the study. Vitamin D insufficiency was defined as a serum 25 (OH) vitamin D level of less than 20 ng/mL. Severe MIS-C was classified as necessitating intensive care due to cardiovascular instability, the necessity for non-invasive or invasive mechanical ventilation, and/or a diminishing Glasgow coma scale. World Health Organization definition criteria were used to describe the clinical stages of COVID-19 in children and patients were divided into four groups according to the clinical severity of COVID-19: asymptomatic, mild, moderate, and severe/critical.
The median serum 25 (OH) vitamin D was 14.6 ng/mL in patients with MIS-C, 16 ng/mL in patients with COVID-19, and 21.1 ng/mL in the control group (p<0.001). Vitamin D insufficiency was present in 74.5% (n=38) of patients with MIS-C, 66.7% (n=38) of patients with COVID-19, and 41.7% (n=25) of the controls (p=0.001). The percentage of four or more affected organ systems was 39.2% in patients with MIS-C. The correlation between the number of affected organ systems and serum 25 (OH) vitamin D levels was evaluated in patients with MIS-C and there was a moderate negative correlation (r=-0.310; p=0.027). A weak negative correlation was found between the severity of COVID-19 and serum 25 (OH) vitamin D (r=-0.320, p=0.015).
Vitamin D levels were insufficient in both the MIS-C and COVID groups. Furthermore, vitamin D levels correlated with the number of affected organ systems in MIS-C and the severity of COVID-19.
确定儿童多系统炎症综合征(MIS-C)患儿血清 25-羟维生素 D 水平的临床意义,并比较这些患儿与 2019 年冠状病毒病(COVID-19)患儿和健康对照者的维生素 D 水平。
本研究设计为年龄在 1 个月至 18 岁的儿科患者,于 2021 年 7 月 14 日至 12 月 25 日进行。纳入 51 例 MIS-C 患儿、57 例因 COVID-19 住院的患儿和 60 例对照者。血清 25(OH)维生素 D 水平<20ng/ml 定义为维生素 D 不足。严重 MIS-C 定义为心血管不稳定、需要无创或有创机械通气以及/或格拉斯哥昏迷量表评分降低而需要重症监护。采用世界卫生组织(WHO)儿童 COVID-19 临床分期标准描述 COVID-19 患儿的临床分期,并根据 COVID-19 的临床严重程度将患儿分为 4 组:无症状、轻症、中症和重症/危重症。
MIS-C 患儿的血清 25(OH)维生素 D 中位数为 14.6ng/ml,COVID-19 患儿为 16ng/ml,对照组为 21.1ng/ml(p<0.001)。MIS-C 患儿中维生素 D 不足者占 74.5%(n=38),COVID-19 患儿占 66.7%(n=38),对照组占 41.7%(n=25)(p=0.001)。MIS-C 患儿中 4 个或更多器官系统受累的比例为 39.2%。在 MIS-C 患儿中评估了受累器官系统数量与血清 25(OH)维生素 D 水平之间的相关性,发现存在中度负相关(r=-0.310;p=0.027)。在 COVID-19 患儿中发现 COVID-19 严重程度与血清 25(OH)维生素 D 水平呈弱负相关(r=-0.320,p=0.015)。
MIS-C 组和 COVID-19 组患儿的维生素 D 水平均不足。此外,MIS-C 患儿的维生素 D 水平与受累器官系统数量以及 COVID-19 的严重程度相关。